Detalhe da pesquisa
1.
Overexpression of DDX49 in prostate cancer is associated with poor prognosis.
BMC Urol
; 23(1): 66, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106339
2.
Feasibility and safety of bipolar-plasmakinetic transurethral enucleation and resection of the prostate in day surgery mode. / åæç离åç»å°¿éååè ºååæ¥é´ææ¯ä¸´åºå®è·µ.
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 52(2): 148-155, 2023 Apr 25.
Artigo
em Inglês, Zh
| MEDLINE | ID: mdl-37283098
3.
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
Cancer Cell Int
; 22(1): 382, 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471446
4.
Short- and Long-Term Response of Vagus Nerve Stimulation Therapy in Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis.
Neuromodulation
; 25(3): 327-342, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396068
5.
[Omics molecular subtyping, prognostic prediction and individualized treatment of prostate cancer: Advances in studies].
Zhonghua Nan Ke Xue
; 28(9): 837-842, 2022 Sep.
Artigo
em Zh
| MEDLINE | ID: mdl-37839011
6.
Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations.
Immunotargets Ther
; 13: 111-121, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38435982
7.
Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy.
Comput Struct Biotechnol J
; 21: 74-85, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514337
8.
Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy.
Ann Med
; 55(2): 2279235, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939258
9.
Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer.
Biochem Pharmacol
; 214: 115669, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364622
10.
Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour.
Comput Struct Biotechnol J
; 20: 3399-3408, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35832632
11.
Signature for Prostate Cancer Based on Autophagy-Related Genes and a Nomogram for Quantitative Risk Stratification.
Dis Markers
; 2022: 7598942, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860692
12.
EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort.
Front Pharmacol
; 13: 946637, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36199693
13.
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.
Mol Ther Oncolytics
; 20: 410-421, 2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33665361
14.
Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction.
Clin Transl Med
; 14(1): e1552, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239097
15.
Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis.
J Infect
; 84(6): 834-872, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35341831
16.
Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer.
Clin Transl Med
; 11(12): e655, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936729